Niagen Bioscience, Inc. Common Stock NAGE Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $64.79M+45.1% | $44.66M+63.4% | $27.33M+33.7% | $20.44M-27.6% | ||
| $9.74M+25.4% | $7.77M+48.4% | $5.23M-38.3% | $8.48M+62.3% | ||
| $20.42M+122% | $9.19M-36.7% | $14.53M-1.0% | $14.68M+7.9% | ||
| $96.81M+51.0% | $64.1M+29.4% | $49.53M+6.4% | $46.57M-4.8% | ||
| $1.32M-23.0% | $1.72M-19.6% | $2.14M-23.7% | $2.8M-6.8% | ||
| $5.66M+1,477% | $359K-29.6% | $510K-24.0% | $671K-21.7% | ||
| $106.41M+55.8% | $68.28M+24.2% | $54.96M+1.7% | $54.06M-6.5% | ||
| $10.8M+26.6% | $8.53M-16.7% | $10.23M+5.7% | $9.68M-7.1% | ||
| $399K-34.7% | $611K+213% | $195K+24.2% | $157K-2.5% | ||
| $19.92M+11.0% | $17.95M-13.0% | $20.62M+15.4% | $17.87M+1.5% | ||
| $29.87M+34.7% | $22.18M-16.3% | $26.51M+4.4% | $25.39M-2.8% | ||
| 150M+194,705% | 77K+2.7% | 75K+1.4% | 74K+8.8% | ||
| -$164.53M+9.6% | -$181.91M+4.5% | -$190.46M-2.7% | -$185.49M-9.8% | ||
| $76.53M+66.0% | $46.09M+62.0% | $28.46M-0.8% | $28.67M-9.6% | ||
| $106.41M+55.8% | $68.28M+24.2% | $54.96M+1.7% | $54.06M-6.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Niagen Bioscience, Inc. Common Stock's total assets?
- Niagen Bioscience, Inc. Common Stock (NAGE) holds $114.3M in total assets, up 40.6% year over year.
- How much debt does Niagen Bioscience, Inc. Common Stock have?
- Niagen Bioscience, Inc. Common Stock carries $2.6M in total debt against $82.3M of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Niagen Bioscience, Inc. Common Stock have?
- Niagen Bioscience, Inc. Common Stock holds $66.5M in cash and equivalents.
- Can Niagen Bioscience, Inc. Common Stock cover its short-term obligations?
- Its current ratio is 4.61 — current assets exceed current liabilities.
- Where does Niagen Bioscience, Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Niagen Bioscience, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
